Год
2023
-
Kintara’s VAL-083 Gets Orphan Drug Status for Rare Childhood Cancer
-
Centrient API Plant Receives Warning Letter
-
Prime to Cover Biosimilars Alongside Humira
-
Intranasal Therapy for Major Depressive Disorder Gets Fast Track Status
-
USP and Phlow Partner to Validate Continuous Manufacturing Processes
-
FDA Advisors Reject Cytokinetics’ Heart Failure Candidate
-
Merck and Moderna’s mRNA cancer vaccine aces its first efficacy trial
-
Rare Disease Moonshot launched at European Health Summit
-
Mirati’s Krazati Gets Accelerated Approval for NSCLC
-
British Pharma Industry Cites Six Companies for Code Violations